Endovascular brachytherapy with (192)Ir and (188)Re to treat de novo and recurrent infrainguinal restenoses

W A Wohlgemuth; G Leissner; H Wengenmair; K Bohndorf; K Kirchhof

Endovascular brachytherapy with (192)Ir and (188)Re to treat de novo and recurrent infrainguinal restenoses

J Cardiovasc Surg (Torino). 2010 Aug;51(4):573-8.

Authors

W A Wohlgemuth¹, G Leissner, H Wengenmair, K Bohndorf, K Kirchhof

Affiliation

¹ Department of Radiology, Klinikum Augsburg, Augsburg, Germany.

PMID: 20671642

Abstract

We present a review of the literature on endovascular brachytherapy (EVBT) after percutaneous transluminal angioplasty (PTA) in the femoropopliteal and tibial arteries. The pathophysiological changes induced by PTA and EVBT within the vessel wall, technical considerations regarding 192Ir and 188Re, the results of clinical trials, and the medication required before, during, and after EVBT are summarized.

Publication types

Review

MeSH terms

Angioplasty, Balloon / adverse effects*
Arterial Occlusive Diseases / radiotherapy
Arterial Occlusive Diseases / therapy*
Brachytherapy / methods*
Constriction, Pathologic
Humans
Iridium Radioisotopes / therapeutic use*
Lower Extremity / blood supply*
Radioisotopes / therapeutic use*
Recurrence
Rhenium / therapeutic use*
Treatment Outcome

Substances

Iridium Radioisotopes
Radioisotopes
Rhenium